Nifty

:

15746.45

Sensex

:

52578.76

-78.00 (-0.49%)
-316.65 (-0.60%)

Login

Nifty
Sensex

:
:

15746.45
52578.76

-78.00 (-0.49%)
-316.65 (-0.60%)

Sequent Scientific Ltd.

Pharmaceuticals & Drugs - Veterinary

Rating :

61/99

BSE: 512529 | NSE: SEQUENT

Watchlist

NSE BSE

308.65

27-Jul-2021

Open
High
Low
Previous Close

304.90
311.90
292.00
303.35

Volume
Traded Value (lacs)
52 Week High
52 Week Low

1843866
5578.61
336.50
109.55

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

7,536.82
78.97
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

7,791.64
0.16%
10.36

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

14.22
13.54
4.59

EBITDA CAGR (%)

10 Years
5 Years
3 Years

14.11
24.60
8.84

PAT CAGR (%)

10 Years
5 Years
3 Years

2.97
15.48
-45.06

P:E (Median)

8 Years
5 Years
3 Years

-
28.78
32.76

P:BV (Average)

8 Years
5 Years
3 Years

7.72
3.57
4.05

EV:EBITDA (Average)

8 Years
5 Years
3 Years

59.17
24.30
18.25

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 21 Mar 20 Var% Dec 20 Dec 19 Var% Sep 20 Sep 19 Var% Jun 20 Jun 19 Var%
Net Sales 69.48 62.29 11.54% 70.57 61.80 14.19% 69.64 51.52 35.17% 59.24 51.72 14.54%
Expenses 66.60 51.76 28.67% 57.34 55.94 2.50% 59.17 48.72 21.45% 49.46 48.68 1.60%
EBITDA 2.88 10.54 -72.68% 13.24 5.86 125.94% 10.47 2.80 273.93% 9.79 3.04 222.04%
EBIDTM 4.14% 16.92% 18.76% 9.49% 15.03% 5.43% 16.52% 5.87%
Other Income 5.92 3.05 94.10% 5.67 2.22 155.41% 6.10 7.26 -15.98% 2.27 2.03 11.82%
Interest 0.25 1.23 -79.67% 0.60 1.19 -49.58% 0.73 1.19 -38.66% 1.10 1.42 -22.54%
Depreciation 2.61 2.31 12.99% 2.19 2.19 0.00% 2.16 2.23 -3.14% 2.16 2.23 -3.14%
PBT 6.03 10.06 -40.06% 16.11 4.69 243.50% 11.03 6.64 66.11% 8.80 1.42 519.72%
Tax 1.39 3.24 -57.10% 3.94 1.77 122.60% 1.82 -3.54 - 1.87 0.00 0
PAT 4.64 6.82 -31.96% 12.17 2.92 316.78% 9.21 10.18 -9.53% 6.92 1.42 387.32%
PATM 6.68% 10.94% 17.24% 4.72% 13.23% 19.77% 11.69% 2.75%
EPS 0.19 0.27 -29.63% 0.49 0.12 308.33% 0.37 0.41 -9.76% 0.28 0.06 366.67%

Description Mar 21 Mar 20 Var% Dec 20 Dec 19 Var% Sep 20 Sep 19 Var% Jun 20 Jun 19 Var%
Net Sales 361.82 300.58 20.37% 358.21 316.42 13.21% 346.27 284.22 21.83% 310.26 278.02 11.60%
Expenses 318.54 255.85 24.50% 291.91 266.44 9.56% 289.88 247.06 17.33% 259.25 239.57 8.21%
EBITDA 43.28 44.74 -3.26% 66.31 49.98 32.67% 56.39 37.16 51.75% 51.02 38.44 32.73%
EBIDTM 11.96% 14.88% 18.51% 15.80% 16.29% 13.07% 16.44% 13.83%
Other Income 1.37 1.83 -25.14% 2.81 0.98 186.73% 2.64 5.97 -55.78% 1.55 1.31 18.32%
Interest 3.18 9.33 -65.92% 6.20 9.60 -35.42% 7.36 7.84 -6.12% 7.65 8.95 -14.53%
Depreciation 12.68 13.09 -3.13% 11.58 13.05 -11.26% 13.30 12.46 6.74% 13.03 12.01 8.49%
PBT 29.01 24.14 20.17% 51.33 28.31 81.31% 29.32 22.83 28.43% 31.89 18.80 69.63%
Tax 5.49 5.91 -7.11% 11.64 4.25 173.88% 7.96 -1.64 - 7.42 3.50 112.00%
PAT 23.52 18.23 29.02% 39.69 24.06 64.96% 21.36 24.47 -12.71% 24.47 15.30 59.93%
PATM 6.50% 6.06% 11.08% 7.60% 6.17% 8.61% 7.89% 5.50%
EPS 0.83 0.68 22.06% 1.50 0.82 82.93% 0.86 0.86 0.00% 0.84 0.46 82.61%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 268.93 227.33 166.26 271.20 105.87 394.59 444.82 445.08 235.77 332.43 277.98 Net Sales Growth 18.30% 36.73% -38.69% 156.16% -73.17% -11.29% -0.06% 88.78% -29.08% 19.59% Cost Of Goods Sold 110.83 113.04 94.62 161.37 72.47 218.33 229.86 245.55 133.20 190.11 140.26 Gross Profit 158.10 114.29 71.64 109.83 33.40 176.26 214.95 199.53 102.57 142.32 137.72 GP Margin 58.79% 50.27% 43.09% 40.50% 31.55% 44.67% 48.32% 44.83% 43.50% 42.81% 49.54% Total Expenditure 232.57 205.10 163.57 258.06 121.27 359.06 384.54 437.81 253.85 296.96 231.01 Power & Fuel Cost - 12.73 8.52 2.32 2.14 17.98 20.68 21.77 17.98 20.21 15.68 % Of Sales - 5.60% 5.12% 0.86% 2.02% 4.56% 4.65% 4.89% 7.63% 6.08% 5.64% Employee Cost - 17.10 10.71 25.12 17.90 38.84 45.47 42.87 29.10 25.44 22.70 % Of Sales - 7.52% 6.44% 9.26% 16.91% 9.84% 10.22% 9.63% 12.34% 7.65% 8.17% Manufacturing Exp. - 51.52 41.13 15.87 14.85 56.50 48.54 49.63 34.33 26.30 28.23 % Of Sales - 22.66% 24.74% 5.85% 14.03% 14.32% 10.91% 11.15% 14.56% 7.91% 10.16% General & Admin Exp. - 8.55 7.15 13.02 9.92 15.19 23.99 41.71 14.93 10.56 16.58 % Of Sales - 3.76% 4.30% 4.80% 9.37% 3.85% 5.39% 9.37% 6.33% 3.18% 5.96% Selling & Distn. Exp. - 2.11 1.04 0.83 0.47 4.03 5.71 7.90 7.03 9.12 7.21 % Of Sales - 0.93% 0.63% 0.31% 0.44% 1.02% 1.28% 1.77% 2.98% 2.74% 2.59% Miscellaneous Exp. - 0.04 0.40 39.53 3.53 8.19 10.29 28.37 17.28 15.22 7.21 % Of Sales - 0.02% 0.24% 14.58% 3.33% 2.08% 2.31% 6.37% 7.33% 4.58% 0.12% EBITDA 36.38 22.23 2.69 13.14 -15.40 35.53 60.28 7.27 -18.08 35.47 46.97 EBITDA Margin 13.53% 9.78% 1.62% 4.85% -14.55% 9.00% 13.55% 1.63% -7.67% 10.67% 16.90% Other Income 19.96 14.56 13.96 24.67 19.07 15.55 3.56 5.25 2.92 11.33 11.41 Interest 2.68 5.04 3.22 4.54 0.42 16.44 47.46 38.74 24.64 28.27 20.04 Depreciation 9.12 8.95 7.22 14.37 3.25 24.18 26.38 27.13 23.00 21.03 17.18 PBT 41.97 22.81 6.20 18.90 -0.01 10.46 -9.99 -53.34 -62.81 -2.50 21.16 Tax 9.02 1.47 -1.38 2.87 0.00 0.07 1.70 0.00 -8.31 -3.96 6.28 Tax Rate 21.49% 6.44% -22.26% 0.70% 0.00% 0.67% 3.95% 0.00% 13.23% 158.40% 28.28% PAT 32.94 21.34 7.59 406.41 -0.01 10.39 41.31 -114.42 -54.50 1.47 15.93 PAT before Minority Interest 32.94 21.34 7.59 406.41 -0.01 10.39 41.31 -114.42 -54.50 1.47 15.93 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 12.25% 9.39% 4.57% 149.86% -0.01% 2.63% 9.29% -25.71% -23.12% 0.44% 5.73% PAT Growth 54.36% 181.16% -98.13% - - -74.85% - - - -90.77% EPS 1.33 0.86 0.31 16.36 0.00 0.42 1.66 -4.61 -2.19 0.06 0.64

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 1,376.56 1,179.24 1,039.31 1,030.59 683.57 624.98 465.36 455.46 326.86 345.81 311.89 Net Sales Growth 16.73% 13.46% 0.85% 50.77% 9.37% 34.30% 2.17% 39.34% -5.48% 10.88% Cost Of Goods Sold 704.29 605.05 543.01 554.23 356.70 311.71 240.72 243.65 181.72 192.27 162.01 Gross Profit 672.27 574.19 496.30 476.36 326.87 313.27 224.65 211.81 145.14 153.53 149.87 GP Margin 48.84% 48.69% 47.75% 46.22% 47.82% 50.12% 48.27% 46.50% 44.40% 44.40% 48.05% Total Expenditure 1,159.58 1,008.92 914.37 919.10 643.03 568.27 444.87 438.68 342.51 308.74 266.39 Power & Fuel Cost - 24.73 23.06 14.66 12.77 26.51 23.32 22.06 23.53 20.21 16.75 % Of Sales - 2.10% 2.22% 1.42% 1.87% 4.24% 5.01% 4.84% 7.20% 5.84% 5.37% Employee Cost - 165.06 145.95 132.07 106.22 88.62 62.39 48.12 41.47 29.40 29.82 % Of Sales - 14.00% 14.04% 12.81% 15.54% 14.18% 13.41% 10.57% 12.69% 8.50% 9.56% Manufacturing Exp. - 83.24 77.73 59.07 57.63 72.14 54.31 52.30 41.42 27.88 33.72 % Of Sales - 7.06% 7.48% 5.73% 8.43% 11.54% 11.67% 11.48% 12.67% 8.06% 10.81% General & Admin Exp. - 56.37 58.35 70.92 48.60 36.44 33.79 43.58 23.96 13.69 15.95 % Of Sales - 4.78% 5.61% 6.88% 7.11% 5.83% 7.26% 9.57% 7.33% 3.96% 5.11% Selling & Distn. Exp. - 45.16 36.29 36.87 28.78 17.46 20.27 12.30 10.51 9.23 7.52 % Of Sales - 3.83% 3.49% 3.58% 4.21% 2.79% 4.36% 2.70% 3.22% 2.67% 2.41% Miscellaneous Exp. - 29.32 29.98 51.29 32.34 15.40 10.07 16.66 19.91 16.05 7.52 % Of Sales - 2.49% 2.88% 4.98% 4.73% 2.46% 2.16% 3.66% 6.09% 4.64% 0.20% EBITDA 217.00 170.32 124.94 111.49 40.54 56.71 20.49 16.78 -15.65 37.07 45.50 EBITDA Margin 15.76% 14.44% 12.02% 10.82% 5.93% 9.07% 4.40% 3.68% -4.79% 10.72% 14.59% Other Income 8.37 10.09 8.67 17.20 11.08 14.30 9.96 3.84 4.96 10.48 6.69 Interest 24.39 35.71 32.80 39.70 28.34 38.56 44.37 39.04 33.45 29.99 23.80 Depreciation 50.59 50.62 41.92 53.30 40.07 46.22 32.94 32.60 28.61 22.98 20.69 PBT 141.55 94.08 58.88 35.70 -16.80 -13.77 -46.85 -51.00 -72.75 -5.41 7.69 Tax 32.51 12.03 2.01 13.46 -0.41 2.62 3.39 0.58 -8.06 -3.95 7.51 Tax Rate 22.97% 12.79% 3.41% 3.03% 2.44% -19.03% -40.50% -0.53% 11.08% 73.01% 215.80% PAT 109.04 69.91 48.66 421.57 -13.83 -18.47 -10.74 -110.49 -64.69 -1.40 -0.17 PAT before Minority Interest 100.04 82.05 56.88 430.83 -16.39 -16.39 -11.76 -110.49 -64.69 -1.46 -4.02 Minority Interest -9.00 -12.14 -8.22 -9.26 2.56 -2.08 1.02 0.00 0.00 0.06 3.85 PAT Margin 7.92% 5.93% 4.68% 40.91% -2.02% -2.96% -2.31% -24.26% -19.79% -0.40% -0.05% PAT Growth 32.88% 43.67% -88.46% - - - - - - - EPS 4.39 2.81 1.96 16.97 -0.56 -0.74 -0.43 -4.45 -2.60 -0.06 -0.01

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 886.22 917.79 948.62 1,257.33 1,205.88 156.92 50.25 109.45 126.71 125.55 Share Capital 49.67 49.37 48.75 48.75 47.65 30.48 26.74 23.44 21.34 21.23 Total Reserves 822.45 849.53 882.29 1,193.03 1,134.19 92.50 11.15 74.13 105.37 104.31 Non-Current Liabilities 11.50 36.20 19.01 38.28 42.08 79.95 109.66 113.91 85.77 111.68 Secured Loans 15.16 20.61 0.00 13.98 23.82 56.70 90.47 107.52 61.38 86.83 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.35 0.56 0.72 0.88 1.04 Long Term Provisions 4.09 22.30 24.39 28.88 22.84 22.97 18.70 5.68 15.27 11.52 Current Liabilities 105.24 79.87 26.69 168.71 109.89 427.45 414.42 319.83 298.94 190.96 Trade Payables 64.34 52.60 24.56 69.96 73.64 69.81 135.38 145.92 122.57 78.41 Other Current Liabilities 9.30 6.01 1.91 35.29 20.85 86.85 31.38 27.75 71.60 33.88 Short Term Borrowings 14.39 19.27 0.00 63.22 15.04 270.29 241.08 139.47 98.09 68.90 Short Term Provisions 17.22 1.99 0.21 0.24 0.36 0.51 6.58 6.70 6.68 9.77 Total Liabilities 1,002.96 1,033.86 994.32 1,464.32 1,357.85 664.32 574.33 543.19 511.42 428.19 Net Block 69.41 52.42 23.68 181.67 169.60 200.88 219.93 205.10 206.29 185.49 Gross Block 99.30 73.33 37.61 230.34 193.00 302.01 338.33 301.32 276.44 235.90 Accumulated Depreciation 29.89 20.90 13.93 48.67 23.40 101.13 118.40 96.22 70.15 50.41 Non Current Assets 879.01 946.46 853.77 1,095.85 1,056.39 421.95 333.95 321.05 293.54 264.65 Capital Work in Progress 3.72 0.03 3.12 32.26 19.97 8.93 11.12 21.51 17.57 16.44 Non Current Investment 738.95 788.16 672.67 834.62 834.87 183.11 65.04 54.57 38.81 13.56 Long Term Loans & Adv. 65.53 83.27 138.79 26.79 23.08 26.30 36.20 38.56 28.57 48.13 Other Non Current Assets 1.39 22.57 15.51 20.52 8.86 2.73 1.66 1.30 2.30 1.02 Current Assets 123.95 87.41 140.54 368.46 301.47 242.38 240.38 222.13 217.89 163.54 Current Investments 18.75 0.10 13.98 62.28 62.29 0.08 0.08 0.18 0.28 0.33 Inventories 31.42 25.33 13.83 62.53 56.19 66.88 101.25 82.67 63.11 61.47 Sundry Debtors 40.79 42.90 78.47 113.03 73.75 98.77 79.66 70.16 82.48 53.01 Cash & Bank 3.72 1.88 3.04 3.06 4.80 27.38 19.13 31.07 15.77 5.78 Other Current Assets 29.27 1.56 1.13 12.88 104.45 49.28 40.26 38.05 56.26 42.95 Short Term Loans & Adv. 25.66 15.65 30.09 114.68 86.38 30.28 36.32 32.06 50.48 41.20 Net Current Assets 18.71 7.54 113.85 199.75 191.58 -185.08 -174.04 -97.69 -81.05 -27.42 Total Assets 1,002.96 1,033.87 994.31 1,464.31 1,357.86 664.33 574.33 543.18 511.43 428.19

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 742.76 706.69 647.58 976.79 945.71 91.27 56.73 95.00 122.53 123.06 Share Capital 49.67 49.37 48.75 48.75 47.65 30.48 26.74 23.44 21.34 21.23 Total Reserves 679.00 638.43 581.25 912.49 874.01 26.85 -0.37 59.68 101.19 101.82 Non-Current Liabilities 241.56 214.75 227.13 246.20 299.72 277.55 159.23 144.35 104.79 123.22 Secured Loans 107.97 126.94 85.14 141.76 197.50 249.97 150.52 137.32 80.19 90.73 Unsecured Loans 42.09 20.90 18.40 23.38 13.82 0.35 0.56 0.72 0.88 8.46 Long Term Provisions 13.16 30.50 28.54 34.76 28.66 25.70 8.03 6.09 15.49 11.74 Current Liabilities 479.57 440.41 430.93 663.55 290.37 406.09 405.28 345.41 329.56 199.21 Trade Payables 220.38 209.35 160.49 203.04 143.94 90.94 114.59 150.91 123.94 82.61 Other Current Liabilities 92.65 87.80 106.52 259.26 83.23 107.43 56.80 35.63 75.38 37.71 Short Term Borrowings 134.36 127.36 152.41 194.70 56.04 204.31 226.60 151.76 123.34 69.09 Short Term Provisions 32.19 15.90 11.51 6.54 7.17 3.42 7.29 7.12 6.89 9.80 Total Liabilities 1,508.63 1,402.10 1,342.62 1,903.76 1,538.02 921.84 625.82 589.34 562.37 446.25 Net Block 632.23 498.14 475.97 684.33 586.48 474.43 237.59 227.26 229.76 210.76 Gross Block 818.12 638.06 581.74 789.60 643.70 596.25 369.07 330.69 305.11 264.26 Accumulated Depreciation 185.89 139.91 105.77 105.27 57.22 121.82 131.48 103.43 75.35 53.50 Non Current Assets 794.52 795.99 804.61 1,176.02 1,047.48 612.00 359.87 358.31 351.94 282.23 Capital Work in Progress 13.42 22.61 18.04 32.55 23.52 39.06 43.04 88.71 64.07 19.53 Non Current Investment 131.29 179.65 221.73 363.97 360.58 58.04 0.04 1.64 0.04 0.05 Long Term Loans & Adv. 14.40 32.27 31.01 37.51 30.35 36.01 76.06 39.28 55.77 50.87 Other Non Current Assets 3.18 63.31 57.86 57.66 46.54 4.47 3.15 1.42 2.30 1.02 Current Assets 714.11 606.12 538.01 727.74 490.54 309.84 265.94 231.04 210.42 164.02 Current Investments 40.18 0.47 17.34 64.12 66.98 0.58 0.08 0.18 0.28 0.33 Inventories 219.42 200.10 158.57 160.81 135.08 94.36 101.40 85.62 68.24 65.55 Sundry Debtors 318.76 278.25 258.35 254.62 192.39 115.44 83.54 65.81 70.41 55.45 Cash & Bank 75.83 72.04 42.45 47.40 25.30 38.46 36.21 33.00 35.88 9.17 Other Current Assets 59.92 8.51 5.25 146.31 70.80 61.01 44.71 46.44 35.62 33.52 Short Term Loans & Adv. 44.41 46.75 56.05 54.48 46.69 41.86 37.47 36.48 28.84 31.25 Net Current Assets 234.54 165.71 107.08 64.19 200.17 -96.25 -139.34 -114.37 -119.13 -35.19 Total Assets 1,508.63 1,402.11 1,342.62 1,903.76 1,538.02 921.84 625.81 589.35 562.36 446.25

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 30.20 73.80 -4.02 -24.04 100.02 -24.99 -42.37 -12.70 10.40 48.77 PBT 22.81 6.20 409.27 -0.01 10.46 43.01 -114.42 -62.81 -2.50 22.21 Adjustment 1.74 -2.19 -392.74 20.30 33.58 22.54 136.20 61.04 42.30 22.10 Changes in Working Capital 7.84 70.32 -21.10 -42.97 56.92 -89.22 -63.80 -11.41 -26.13 10.05 Cash after chg. in Working capital 32.39 74.34 -4.57 -22.68 100.95 -23.68 -42.01 -13.18 13.68 54.37 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -2.19 -0.54 0.55 -1.36 -0.93 -1.31 -0.35 0.48 -3.28 -5.60 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -10.38 -114.06 15.60 -46.84 -359.41 23.65 -60.82 -31.29 -41.11 -68.34 Net Fixed Assets -29.66 -32.63 221.87 -49.63 97.97 38.51 -26.62 -28.82 -41.67 -80.90 Net Investments 30.56 -101.61 210.25 0.26 -713.97 -118.07 -10.37 -15.66 -25.20 31.50 Others -11.28 20.18 -416.52 2.53 256.59 103.21 -23.83 13.19 25.76 -18.94 Cash from Financing Activity -18.01 40.34 -11.78 70.97 247.38 7.96 107.56 38.81 31.58 12.85 Net Cash Inflow / Outflow 1.81 0.07 -0.19 0.09 -12.01 6.62 4.37 -5.17 0.87 -6.71 Opening Cash & Equivalents 1.07 1.00 1.19 1.10 13.11 6.48 2.11 7.29 5.78 12.44 Closing Cash & Equivalent 2.87 1.07 1.00 1.19 1.10 13.10 6.48 2.11 7.29 5.78

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 115.33 116.02 45.24 -7.19 -0.05 -23.55 -44.78 -3.82 21.48 49.63 PBT 94.08 58.88 445.79 -16.80 -13.77 -8.37 -109.91 -72.75 -5.41 3.49 Adjustment 91.41 84.47 -313.85 123.31 83.81 35.92 133.52 65.98 46.98 36.77 Changes in Working Capital -58.30 -27.95 -77.87 -104.37 -71.46 -53.98 -67.45 2.48 -17.29 15.96 Cash after chg. in Working capital 127.18 115.40 54.06 2.14 -1.42 -26.44 -43.84 -4.28 24.27 56.22 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -11.85 0.62 -8.83 -9.33 1.37 2.89 -0.95 0.46 -2.79 -6.59 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -72.27 -67.69 7.17 -116.18 -315.83 -154.69 -79.95 -54.89 -66.78 -71.77 Net Fixed Assets -29.66 -32.63 221.87 -49.63 97.97 38.51 -26.62 -28.82 -41.67 -80.90 Net Investments 30.56 -101.61 210.25 0.26 -713.97 -118.07 -10.37 -15.66 -25.20 31.50 Others -73.17 66.55 -424.95 -66.81 300.17 -75.13 -42.96 -10.41 0.09 -22.37 Cash from Financing Activity -42.75 -20.08 -56.96 147.44 308.69 179.41 145.54 34.70 61.94 16.51 Net Cash Inflow / Outflow 0.31 28.25 -4.55 24.07 -7.19 1.17 20.80 -24.02 16.63 -5.62 Opening Cash & Equivalents 67.79 39.54 44.10 20.03 21.85 22.96 3.45 27.37 9.17 14.07 Closing Cash & Equivalent 68.10 67.79 39.54 44.10 20.03 21.83 22.96 3.45 27.37 9.17

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 35.11 36.41 38.20 50.95 49.61 8.07 2.83 8.33 11.88 11.82 ROA 2.10% 0.75% 33.06% 0.00% 1.03% 6.67% -20.48% -10.34% 0.31% 4.14% ROE 2.41% 0.83% 37.41% 0.00% 1.59% 51.35% -168.93% -48.60% 1.16% 13.16% ROCE 2.96% 0.99% 36.09% 0.03% 3.07% 20.15% -19.54% -10.55% 7.93% 15.27% Fixed Asset Turnover 2.66 3.00 2.05 0.52 1.65 1.45 1.45 0.85 1.35 1.48 Receivable days 66.55 132.93 127.17 310.76 77.04 70.28 58.94 113.28 71.66 62.69 Inventory Days 45.13 42.89 50.71 197.54 54.96 66.23 72.35 108.19 65.88 68.83 Payable days 103.60 86.82 78.05 239.99 74.47 102.24 128.36 197.86 122.93 105.70 Cash Conversion Cycle 8.08 88.99 99.83 268.31 57.53 34.27 2.92 23.61 14.61 25.82 Total Debt/Equity 0.04 0.05 0.00 0.07 0.04 2.77 9.23 2.72 1.75 1.40 Interest Cover 5.53 2.93 91.09 0.97 1.64 1.91 -1.95 -1.55 0.91 2.11

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 29.34 27.86 25.85 39.44 38.69 3.76 1.97 7.09 11.48 11.59 ROA 5.64% 4.14% 26.54% -0.95% -1.33% -1.52% -18.19% -11.23% -0.29% -0.97% ROE 11.58% 8.63% 54.15% -1.74% -3.35% -28.10% -201.83% -62.91% -1.19% -3.42% ROCE 12.33% 9.24% 41.28% 0.87% 2.72% 6.93% -16.09% -9.86% 6.98% 9.11% Fixed Asset Turnover 1.65 1.74 1.51 0.96 1.03 1.01 1.36 1.08 1.26 1.31 Receivable days 90.45 92.53 90.49 118.40 87.75 74.80 57.30 72.70 64.08 63.08 Inventory Days 63.56 61.85 56.34 78.37 65.41 73.58 71.75 82.12 68.11 69.36 Payable days 80.87 75.36 77.04 104.11 77.28 87.31 115.68 149.32 123.09 94.20 Cash Conversion Cycle 73.14 79.02 69.78 92.66 75.87 61.07 13.36 5.51 9.10 38.25 Total Debt/Equity 0.45 0.47 0.48 0.43 0.34 8.26 15.86 3.74 2.19 1.54 Interest Cover 3.63 2.80 12.19 0.41 0.64 0.81 -1.82 -1.18 0.82 1.15

Top Investors:

infinity holdings

unit trust of india investment advisory services limited a/c ascent india fund iii

sbi healthcare opportunities fund

ashoka india opportunities fund

Annual Reports:

News Update:

SeQuent Scientific gets EUGMP approval for tablets dosage manufacturing line in Turkey
15th Jul 2021, 09:23 AM

The company has already embarked upon significant expansion in Turkey to meet the growing requirements of the local market
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback